Articles On Telix Pharmaceuticals (ASX:TLX)
| Title | Source | Codes | Date |
|---|---|---|---|
|
ASX 200 Health Sector Update on Clinical Momentum and Discovery Pathways
Highlights Australian health companies reported progress across diagnostics, therapeutics, and clinical development Research milestones and regulatory updates shaped quarterly activity in the healthcare space ASX-listed heal... |
Kalkine Media | TLX | 17 hours ago |
|
3 ASX stocks every Aussie investor should consider in 2026
It's been a subdued start to the year for ASX stocks. The S&P/ASX 300 Index (ASX: XKO) is 1.57% higher for the year-to-date, and the S&P/ASX 200 Index (ASX: XJO) is up 1.62% as cost-of-living pressures, cash rate hike concerns and m... |
Motley Fool | TLX | 20 hours ago |
|
Down 60%, is there a once-in-a-decade opportunity in this ASX 200 stock?
A 60% share price fall in just 12 months is enough to scare off even confident investors. When it happens to a popular ASX 200 stock, it naturally raises a hard question. Is this a value opportunity, or a warning sign? In the case of Tel... |
Motley Fool | TLX | 1 day ago |
|
Biocurious: What to expect in a ‘difficult’ profit-reporting season for healthcare stocks
Given the sector’s travails, investors should delve into the February earnings disclosures even more diligently than usual Despite their defensive reputation, healthcare stocks have, on the whole, done poorly post pandemic In most cases, d... |
Stockhead | TLX | 2 days ago |
|
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) enjoyed a euphoric start to the short trading week this Tuesday. Investors seemed to come back from the long weekend feeling refreshed and invigorated, if the share mark... |
Motley Fool | TLX | 2 days ago |
|
Closing Bell: ASX rips higher as BHP knocks off CBA’s crown
ASX surges 0.92% with nine of 11 sectors higher Strong breadth; 127 stocks rising and just 65 falling Telecoms and materials lead gains with support from banks BHP dethrones Commonwealth Bank A broad surge in metals almost across the bo... |
Stockhead | TLX | 2 days ago |
|
ASX 200 Watch: Market Momentum Builds Across Key Sectors
Highlights Materials and energy names continue to dominate market attention Sector-wide momentum reflects shifting demand and capital flows Select ASX 200 companies show renewed strength across key industries Market mo... |
Kalkine Media | TLX | 2 days ago |
|
ASX 200 Momentum Watch: Market Signals Behind Fresh Highs and Lows
Highlights Strong momentum continues across key resource-led sectors Market leadership shifts reveal deeper structural trends Volatility highlights changing sentiment across major ASX groups The ASX market shows renewe... |
Kalkine Media | TLX | 2 days ago |
|
Weekly Ratings, Targets, Forecast Changes – 23-01-26
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha... |
FNArena | TLX | 3 days ago |
|
These are the 10 most shorted ASX shares
At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels... |
Motley Fool | TLX | 3 days ago |
|
Scott Power: ASX healthcare lifts as focus turns to reporting season
ASX health sector up 0.53% for the week, while broader market rises 0.36% Companies start reporting quarterly results next week ahead of half-year reporting season Third US clinical site approved for Imricor’s VISABL‑AFL trial to support U... |
Stockhead | TLX | 6 days ago |
|
3 ASX 200 shares I would buy before February
With February reporting season fast approaching, investors face a familiar decision. Do you wait for results and risk paying a higher price, or do you act early and accept the uncertainty that comes with buying ahead of updates? If I we... |
Motley Fool | TLX | 1 week ago |
|
Australian Equity Market Context Across ASX 200 and ASX 300
Highlights Selected Australian listed companies operate across healthcare and technology sectors. These companies form part of broader ASX 200 and ASX 300 market benchmarks. Sector positioning reflects diverse operational mo... |
Kalkine Media | TLX | 1 week ago |
|
Focus On Telix’ Guidance Post Annus Horribilis
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin As Telix Pharmaceuticals turns the page on 2025, its annus horribilis, analysts rema... |
FNArena | TLX | 1 week ago |
|
3 ASX shares tipped to climb over 100% in 2026
The S&P/ASX 200 Index (ASX: XJO) closed 0.37% lower on Wednesday afternoon. For the year-to-date the index is 0.63% higher and it's 4.53% above where it was this time last year. The index hasn't posted mind-blowing gains so far this... |
Motley Fool | TLX | 1 week ago |
|
Top broker tips 57% upside for beaten-down Telix shares
Telix Pharmaceuticals Ltd (ASX: TLX) shares are sinking today. Shares in the S&P/ASX 200 Index (ASX: XJO) diagnostic and therapeutic product developer closed yesterday trading for $11.49. During the Wednesday lunch hour, shares are chan... |
Motley Fool | TLX | 1 week ago |
|
Health Check: Ticker device giant backs Anteris Technologies’ hearty $430m-plus raise
Anteris plans a US$200 million ($300 million) raising, with a “concurrent” US$90m private placement to heart device giant Medtronic Telix meets its full year guidance after a December quarter revenue surge Audeara boosts December quarter... |
Stockhead | TLX | 1 week ago |
|
Market Open: Wall Street’s back for WK4, and with it comes chaotic (down) day | Jan 21
ASX today − Losses are gathering steam this morning, with U.S. trading starting a day later thanks to Wall Street’s Monday holiday, and it’s sending our Australian shares towards a -0.4% open when the bell rings in Sydney. Listen to the... |
themarketonline.com.au | TLX | 1 week ago |
|
Telix shares in focus as the company meets guidance
Shares in Telix Pharmaceuticals Ltd (ASX: TLX) will be on watch this morning after the company late yesterday revealed it had met its full year revenue guidance and had grown its fourth quarter revenue strongly. The drug developer said i... |
Motley Fool | TLX | 1 week ago |
|
5 things to watch on the ASX 200 on Wednesday
On Tuesday, the S&P/ASX 200 Index (ASX: XJO) was out of form again and tumbled into the red. The benchmark index dropped 0.65% to 8,815.9 points. Will the market be able to bounce back from this on Wednesday? Here are five things to w... |
Motley Fool | TLX | 1 week ago |
|
Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Ind., Jan. 20, 2026 /PRNewswire/ — Telix P... |
FNArena | TLX | 1 week ago |
|
Why Bellevue Gold, DroneShield, Hub24, and Telix shares are storming higher today
The S&P/ASX 200 Index (ASX: XJO) is on course to record another decline. In afternoon trade, the benchmark index is down 0.6% to 8,821 points. Four ASX shares that have not let that hold them back today are listed below. Here's why the... |
Motley Fool | TLX | 1 week ago |
|
Health Check: A stormy healthcare reporting season approaches, broker warns
RBC Capital Markets says pricing and other pressures are likely to lead to subdued earnings and outlook statements A wave of CEO and CFO departures is clouding the outlook Pacific Edge is confident of regaining US Medicare coverage Invest... |
Stockhead | TLX | 1 week ago |
|
Telix jumps on maiden Chinese application for prostate imaging agent, but short selling increasing
Telix Pharma’s (ASX:TLX) got the Chinese market locked in its sights with a maiden application for Illuccix, a prostate cancer imaging agent, now lodged with (and accepted by) the National Medical Products Application (NMPA). Worth noting i... |
themarketonline.com.au | TLX | 1 week ago |
|
Good news out of China has this drug company's shares higher
Shares in Telix Pharmaceuticals Ltd (ASX: TLX) are trading higher after the company announced good news out of China for its prostate cancer imaging compound, Illuccix. The company said in a statement to the ASX on Tuesday that China's... |
Motley Fool | TLX | 1 week ago |
|
Origin Energy to keep Eraring Power Station running until 2029
The Origin Energy Ltd (ASX: ORG) share price is in focus today after the company announced it will extend operations at the Eraring Power Station until April 2029, providing up to two more years of support for NSW's electricity grid and fur... |
Motley Fool | TLX | 1 week ago |
|
BHP lifts copper guidance after record half-year output
The BHP Ltd (ASX: BHP) share price is in focus today after the miner reported record copper and iron ore production for the half-year ended 31 December 2025, with copper volumes flat at 984 kt and group copper production guidance lifted for... |
Motley Fool | TLX | 1 week ago |
|
HUB24 posts record inflows in Q2 FY26 earnings
The HUB24 Ltd (ASX: HUB) share price is in focus today after the company reported record platform net inflows of $5.6 billion in Q2 FY26, with total Funds Under Administration (FUA) reaching $152.3 billion as at 31 December 2025, up 26% on... |
Motley Fool | TLX | 1 week ago |
|
Chinese NMPA Accepts New Drug Application for Illuccix for Prostate Cancer Imaging
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ — Telix Pharmac... |
FNArena | TLX | 1 week ago |
|
AMP appoints Blair Vernon as CEO, Alexis George to retire
The AMP Ltd (ASX: AMP) share price is in focus today after the company announced Blair Vernon will become the new Group Chief Executive Officer, with Alexis George set to retire after leading major transformation and growth since 2021. What... |
Motley Fool | TLX | 1 week ago |
|
Telix Pharmaceuticals receives China's nod for Illuccix prostate cancer imaging NDA
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus after the company announced the Chinese regulator has accepted the New Drug Application for Illuccix, Telix's lead imaging agent for prostate cancer. The pivotal Phase 3 study... |
Motley Fool | TLX | 1 week ago |
|
Northern Star Resources revises FY26 cost guidance after lower gold sales
The Northern Star Resources Ltd (ASX: NST) share price is in focus after the company revised its FY26 all-in sustaining cost (AISC) guidance to A$2,600â2,800 per ounce. The gold miner also confirmed its annual production guidance will now... |
Motley Fool | TLX | 1 week ago |
|
2 ASX 200 shares that could be top buys for growth
I think it could be a mistake to think that the largest S&P/ASX 200 Index (ASX: XJO) growth shares have finished expanding. For starters, there are reasons why those businesses have been as successful as they have â their product/s... |
Motley Fool | TLX | 1 week ago |
|
ASX 200 Weekly Pulse: Market Positioning Shifts and Sector Signals
Highlights Market positioning shifted quietly across energy, healthcare, and consumer names Resource-linked stocks reflected changing global demand signals Defensive and growth themes showed contrasting momentum Market... |
Kalkine Media | TLX | 1 week ago |
|
Bell Potter says these ASX shares are best buys in January
If you are on the hunt for some of the best ASX shares to buy this month, then it could pay to listen to analysts at Bell Potter. They have revealed a number of shares that they believe are best buys right now and could offer good returns i... |
Motley Fool | TLX | 1 week ago |
|
These are the 10 most shorted ASX shares
At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels... |
Motley Fool | TLX | 1 week ago |
|
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 /PRNewswire/ — Telix Pharmac... |
FNArena | TLX | 1 week ago |
|
3 unstoppable ASX growth stocks to buy even if there's a stock market sell-off in 2026
I hope there is no stock market sell-off in 2026. Markets falling is never pleasant, and volatility can test even experienced investors. That said, whether markets rise steadily or stumble along the way, there are some ASX growth stocks... |
Motley Fool | TLX | 2 weeks ago |
|
These are the 10 most shorted ASX shares
At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels... |
Motley Fool | TLX | 2 weeks ago |
|
Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Jan. 8, 2026 /PRNewswire/ — Telix Pharmace... |
FNArena | TLX | 3 weeks ago |
|
3 phenomenal ASX stocks that could double in 2026
After a tough 2025, many investors are still licking their wounds. Several former market darlings suffered sharp selloffs as AI bubble concerns and company-specific issues weighed heavily on sentiment. But history shows that some of the str... |
Motley Fool | TLX | 3 weeks ago |
|
ASX Market Signals Reveal Stocks Facing Rising Scepticism
Highlights Bearish market positions reveal changing sentiment across key ASX names Energy, food, healthcare and education stocks remain under scrutiny Weekly disclosures offer insights into risk, valuation and market confide... |
Kalkine Media | TLX | 3 weeks ago |
|
These are the 10 most shorted ASX shares
At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels... |
Motley Fool | TLX | 3 weeks ago |
|
The ASX ‘dogs’ set to bark again in 2026
After a poor year, a slew of blue-chip stocks appears poised for a rebound With the right catalyst, share recoveries can be violent and dramatic Institutions will demand remedial action if poor performance persists Many investors prefer t... |
Stockhead | TLX | 3 weeks ago |
|
These were the worst performing ASX 200 shares in 2025
The S&P/ASX 200 Index (ASX: XJO) had a good but not exceptional year. During the 12 months, the benchmark index rose 6.8% to finish at 8,714.3 points. Unfortunately, not all shares climbed with the market. For example, the ASX 200 sha... |
Motley Fool | TLX | 4 weeks ago |
|
ASX 200 Shares Shaping Long-Term Wealth Stories in Australia
Highlights Australian-listed brands with global scale Business models built for durability Market positioning within major ASX indices Australian-listed companies with scalable retail and healthcare models highlight ho... |
Kalkine Media | TLX | 4 weeks ago |
|
2 ASX shares experts think will smash the market in 2026!
If you are looking for big returns in 2026, then read on! That's because experts believe that the ASX shares in this article have the potential to smash the market next year. Here's what they are recommending to clients for the year ahead:... |
Motley Fool | TLX | 4 weeks ago |
|
10 ASX shares I would buy in 2026
Looking ahead in 2026, I think the best investment opportunities on the ASX could come from a mix of proven compounders, long-term growth stories, and businesses that have already shown they can execute through different market conditions.... |
Motley Fool | TLX | 4 weeks ago |
|
In 2036, you will be glad you bought these ASX shares today
I'm a big fan of buy and hold investing and believe it is one of the best ways to grow wealth. But which ASX shares could be worth buying and holding for the long term? Let's take a look at three that I think could be wealth generators over... |
Motley Fool | TLX | 4 weeks ago |
|
These are the 10 most shorted ASX shares
At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels... |
Motley Fool | TLX | 1 month ago |